[Neonatal hemolytic icterus in foals. A study of antibodies in colostrum and serum].

The research article discusses a study that investigated the presence of antibodies to red blood cell antigens in horse colostrum and serum, with the goal of understanding whether these antibodies could induce haemolytic disease in newborn foals.

Overview of the Study

• The study was carried out on material taken from 181 mares that did not show any signs of clinical disease.
• The aim was to determine how many mares produced antibodies that could potentially cause haemolytic disease in foals, a condition that leads to the destruction of red blood cells.

Results of the Study

• Results indicated that 2.8% of the mares tested positive for haemolysins, antibodies that destroy red blood cells. These mares are believed to pose a risk for haemolytic disease in foals.
• In addition, agglutinating antibodies, which cause particles to cluster or stick together, were found in 39.2% of the mares.
• However, it is uncertain whether these antibodies could also pose a danger to foals.

Further Analysis and Case Studies

• A smaller number of samples from the mares were analyzed to confirm or rule out the diagnosis of haemolytic disease. Some of these mares exhibited extremely high concentrations of haemolysins.
• The study then described several specific cases in greater detail to further illustrate these findings.
• The researchers concluded that the data collected from these cases revealed that haemolytic disease can also occur in foals born after a mare’s first pregnancy.

Significance of the Study

• The findings of this research are significant as they enhance the understanding of how certain antibodies in mares can affect the health of newborn foals, particularly in relation to haemolytic disease.
• Knowledge from this study may help in developing strategies to manage or prevent the onset of this condition in foals, potentially improving their survival and health outcomes.